Treatment with Moderna’s experimental mRNA vaccine in combination with Merck’s immunotherapy technology reduced risk of cancer recurrence or death by 44%, the companies said.
Mice treated with the mRNA vaccine, delivered like ones for Covid, showed reduction in tumours & long-term immune memory, says study by Tufts University researchers published in PNAS.
In FY 2025-26, AoN for 55 proposals amounting to Rs 6.73 lakh cr has been accorded by DAC. Both the quantum of AoN given and capital contracts signed, so far, have been the highest in any FY.
COMMENTS